Lupus Nephritis, immunosuppressive agents, Mycophenolic acid, Cyclophosphamide, healthcare costs, cost saving regimen, resource-limited setting, Egypt.
Showing 1 - 25 of >10,000
Lupus Nephritis Trial in Worldwide (Mycophenolate Mofetil/Mycophenolic Acid, Obinutuzumab, Placebo)
Active, not recruiting
- Lupus Nephritis
- Mycophenolate Mofetil/Mycophenolic Acid
- +4 more
-
La Jolla, California
- +45 more
Nov 14, 2022
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Los Angeles (IMPT-514)
Not yet recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- IMPT-514
-
Los Angeles, CaliforniaUniversity of California, Los Angeles (UCLA) Medical Center
Nov 22, 2023
Heart Failure Trial (Telemonitoring follow-up using medical devices and telematic consultations)
Not yet recruiting
- Heart Failure
- Telemonitoring follow-up using medical devices and telematic consultations
- (no location specified)
Dec 7, 2022
Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)
Not yet recruiting
- Recurrent Severe Aplastic Anemia
- Refractory Severe Aplastic Anemia
- Anti-Thymocyte Globulin
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 23, 2023
Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)
Recruiting
- Mycophenolate Mofetil
- +2 more
- Cyclophosphamide
- Mycophenolate Mofetil
-
Changsha, Hunan, Chinathe Second Xiangya Hospital of Central South University
Aug 8, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- ANCA-Associated Glomerulonephritis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Jul 23, 2023
Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,
Recruiting
- Lupus Nephritis
- +2 more
- Methylprednisolone Injectable Suspension
- +2 more
-
Nanjing, Jiangsu, ChinaJiong Zhang
May 8, 2023
Kidney Transplant; Complications Trial in Saint Louis (Once daily immunosuppression regimen, Twice daily immunosuppression
Recruiting
- Kidney Transplant; Complications
- Once daily immunosuppression regimen
- Twice daily immunosuppression regimen
-
Saint Louis, MissouriWashington University
Nov 12, 2021
Lupus Nephritis Trial in Nanjing (RY_SW01 cell injection, Basic treatment)
Recruiting
- Lupus Nephritis
- RY_SW01 cell injection
- Basic treatment
-
Nanjing, Jiangsu, Chinathe Affiliated Drum Tower Hospital, Medical School, Nanjing Univ
Sep 21, 2023
AntiDFS70 Lupus Nephritis
Recruiting
- Systemic Lupus Erythematosus
- anti dfs70 antibodies
-
Sohag, EgyptSohag university Hospital
Nov 6, 2023
Acute Disease Trial in Boston (ECHO CT Intervention, Matched Non-Participating Facilities)
Active, not recruiting
- Acute Disease
- ECHO CT Intervention
- Matched Non-Participating Facilities
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Dec 14, 2022
Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,
Recruiting
- Lupus Nephritis
- +2 more
- KYV-101 anti-CD19 CAR-T cell therapy
- Standard lymphodepletion regimen
-
Denver, Colorado
- +1 more
Jul 7, 2023
Value of Uric Acid as Early Predictor of Lupus Nephritis
Recruiting
- Uric Acid
- Serum uric acid level
-
Assuit, Egyptassuit University
May 29, 2022
Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus Trial in Los Angeles, Atlanta
Recruiting
- Systemic Lupus Erythematosus (SLE)
- +2 more
-
Los Angeles, California
- +1 more
Jul 5, 2023
Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)
Enrolling by invitation
- Refractory Systemic Lupus Erythematosus
- +2 more
- CNCT19 cell injection
-
Peking, ChinaXiaofeng Zeng
Jul 3, 2023
Lupus Nephritis Trial in China (efgartigimod IV, Placebo)
Recruiting
- Lupus Nephritis
- efgartigimod IV
- Placebo
-
Beijing, China
- +9 more
Apr 11, 2023
SLE, Lupus Nephritis, SGLT2 Inhibitors Trial in Mansoura (dapagliflozin, )
Active, not recruiting
- SLE
- +2 more
- dapagliflozin
- placebo
-
Mansoura, EgyptUrology and Nephrology Center
Feb 18, 2023
Perinatal Mortality Trial in Siem Reap (Saving Babies Lives Programme, No Saving Babies Lives Programme)
Recruiting
- Perinatal Mortality
- Saving Babies Lives Programme
- No Saving Babies Lives Programme
-
Siem Reap, CambodiaAngkor Hospital for Children
Jul 15, 2022
Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma:
Completed
- Diffuse Large B-cell Lymphoma
-
East Hanover, New JerseyNovartis
Jun 16, 2023
Economic Analysis of Alliance A041202 CLL Study
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Calgary, Alberta, Canada
- +14 more
Jun 13, 2022
Lupus Nephritis Trial in Philippines, Taiwan (ANX009)
Recruiting
- Lupus Nephritis
- ANX009
-
Angeles City, Philippines
- +6 more
Mar 10, 2023
Blood Loss, Surgical, Blood Loss, Postoperative Trial in Cairo (Misoprostol)
Recruiting
- Blood Loss, Surgical
- Blood Loss, Postoperative
-
Cairo, EgyptFaculty of medicine, Cairo University
Sep 20, 2023
Lupus Nephritis Trial in China (Telitacicept 240 mg, Telitacicept 160 mg, Placebo)
Not yet recruiting
- Lupus Nephritis
- Telitacicept 240 mg
- +2 more
-
Hefei, Anhui, China
- +44 more
Jan 11, 2023